Learn More
Medchemexpress LLC WJ-39 | 3009908-95-3 | 99.6% | 430.32 | 1 ML

Supplier: Medchemexpress LLC HY16232510MM/1ML
WJ-39 is an orally active aldose reductase (AR) inhibitor that improves tubular damage in diabetic nephropathy rats. It functions by activating PINK1/Parkin signaling, promoting mitophagy, and attenuating apoptosis.
- Orally active aldose reductase inhibitor
- Ameliorates renal tubular injury in diabetic nephropathy
- Activates PINK1/Parkin signaling
- Promotes mitophagy
- Attenuates apoptosis
- Relevant to inflammation and metabolic diseases
- Associated with apoptosis, autophagy, and mitochondrial metabolism
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.